BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8781434)

  • 21. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.
    Bullrich F; Morris SW; Hummel M; Pileri S; Stein H; Croce CM
    Cancer Res; 1994 Jun; 54(11):2873-7. PubMed ID: 8187071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L; Parc P; Hassoun J; Birnbaum D
    J Pathol; 1996 Feb; 178(2):128-32. PubMed ID: 8683377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease.
    Ladanyi M; Cavalchire G; Morris SW; Downing J; Filippa DA
    Am J Pathol; 1994 Dec; 145(6):1296-300. PubMed ID: 7527617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
    Ladanyi M; Cavalchire G
    Diagn Mol Pathol; 1996 Sep; 5(3):154-8. PubMed ID: 8866227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of the t(2;5) in Hodgkin's disease.
    Weiss LM; Lopategui JR; Sun LH; Kamel OW; Koo CH; Glackin C
    Blood; 1995 May; 85(10):2845-7. PubMed ID: 7742546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease.
    Herbst H; Anagnostopoulos J; Heinze B; Dürkop H; Hummel M; Stein H
    Blood; 1995 Sep; 86(5):1694-700. PubMed ID: 7655001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation.
    Li G; Salhany KE; Rook AH; Lessin SR
    J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
    Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S
    Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
    Morris SW; Kirstein MN; Valentine MB; Dittmer KG; Shapiro DN; Saltman DL; Look AT
    Science; 1994 Mar; 263(5151):1281-4. PubMed ID: 8122112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.
    Shiota M; Fujimoto J; Takenaga M; Satoh H; Ichinohasama R; Abe M; Nakano M; Yamamoto T; Mori S
    Blood; 1994 Dec; 84(11):3648-52. PubMed ID: 7949120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
    Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
    N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas.
    Simonitsch I; Panzer-Gruemayer ER; Ghali DW; Zoubek A; Radaszkiewicz T; Gadner H; Kovar H
    Br J Haematol; 1996 Mar; 92(4):866-71. PubMed ID: 8616079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis?
    Orscheschek K; Merz H; Hell J; Binder T; Bartels H; Feller AC
    Lancet; 1995 Jan; 345(8942):87-90. PubMed ID: 7815887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.
    Lopategui JR; Sun LH; Chan JK; Gaffey MJ; Frierson HF; Glackin C; Weiss LM
    Am J Pathol; 1995 Feb; 146(2):323-8. PubMed ID: 7856744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma.
    Arber DA; Sun LH; Weiss LM
    Hum Pathol; 1996 Jun; 27(6):590-4. PubMed ID: 8666370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
    Pileri SA; Pulford K; Mori S; Mason DY; Sabattini E; Roncador G; Piccioli M; Ceccarelli C; Piccaluga PP; Santini D; Leone O; Stein H; Falini B
    Am J Pathol; 1997 Apr; 150(4):1207-11. PubMed ID: 9094977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation.
    Delsol G; Lamant L; Mariamé B; Pulford K; Dastugue N; Brousset P; Rigal-Huguet F; al Saati T; Cerretti DP; Morris SW; Mason DY
    Blood; 1997 Mar; 89(5):1483-90. PubMed ID: 9057627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma.
    Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG
    Blood; 1996 May; 87(9):3860-8. PubMed ID: 8611713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein.
    Kourentzi K; Crum M; Patil U; Prebisch A; Chavan D; Vu B; Zeng Z; Litvinov D; Zu Y; Willson RC
    Sci Rep; 2020 Mar; 10(1):5078. PubMed ID: 32193476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.